News | April 05, 2007

Hospira Introduces New Wireless Platform for Medication Infusion Devices

April 6, 2007 - Hospira Inc. introduced a new wireless platform for its medication infusion devices that incorporates leading-edge authentication standards and encryption protocols to assist hospitals in securely transferring data and complying with patient confidentiality regulations. The new technology also provides the first three- in-one wireless multi-band module for an infusion system, enabling hospitals to select any of three frequency modes for communication.

The platform's expanded security options help ensure only designated, approved hospital staff access clinical data transmitted between the devices and hospital information technology systems as part of the intravenous (I.V.) medication administration process. This can help healthcare providers more readily comply with patient confidentiality regulations, such as the Health Insurance Portability and Accountability Act, or HIPAA, in securing patient data against inadvertent release.

Most wireless products, such as mobile phones, pagers and other medical devices, communicate via the 802.11 "b" or "g" modes on the 2.4 GHz band. With Hospira's new platform, hospitals can choose to operate the company's infusion devices in the "b" or "g" modes, as well as the less frequently used "a" (5 GHz band) wireless mode, to help ensure clear, consistent data transmission.

Hospira is currently offering this new capability with the Plum A (R) single-channel infusion device and will be adding it to its Plum A (R)3 triple-channel device, LifeCare PCA(R) patient-controlled analgesia system and Symbiq(TM) infusion system later this year. The devices work in conjunction with the Hospira MedNet(R) system, a scaleable and upgradeable patient safety platform.

Related Content

RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...